Clinical Trial Update: A Clinical Research of CD70-targeted CAR-NKT Cells (CGC738) Therapy in RCC [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating CD70-targeted CAR-NKT cells (CGC738) for advanced clear cell renal cell carcinoma; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma

Drugs mentioned

• CGC738 CAR-NKT Cells

Snippet

Sponsor: RenJi Hospital | Conditions: Advanced Clear Cell Renal Cell Carcinoma | Phase 1 | Status: NOT_YET_RECRUITING